LABORATORY RESEARCH Prostate-Specific G-Protein-Coupled Receptor Collaborates with Loss of PTEN to Promote Prostate Cancer Progression Scientists report a new mouse model combining prostate-specific loss of tumor-suppressor phosphatase and tensin homolog (Pten) with probasin promoter-driven prostate-specific G-protein-coupled receptor (PSGR) overexpression. PSGR overexpression increased LNCaP proliferation, whereas PSGR short hairpin RNA knockdown inhibited proliferation and migration. [Oncogene] Abstract Nonautophagic Cytoplasmic Vacuolation Death Induction in Human PC-3M Prostate Cancer by Curcumin through Reactive Oxygen Species-Mediated Endoplasmic Reticulum Stress Investigators report that curcumin induced apoptosis in LNCaP, DU145, and PC-3 cells but triggered extensive cytoplasmic vacuolation in PC-3M cells. [Sci Rep] Full Article Prostate Sphere-Forming Stem Cells Are Derived from the P63-Expressing Basal Compartment Scientists showed that the sphere-forming prostate stem cells (P-SCs) are P63-expressing cells and reside in the basal compartment. Therefore they designated them as basal P-SCs (P-bSCs). P-bSCs are capable of differentiating into AR+ and CK18+ organoid cells, but organoid cells cannot form spheres. [J Biol Chem] Abstract | Full Article Type 2 Fibroblast Growth Factor Receptor Signaling Preserves Stemness and Prevents Differentiation of Prostate Stem Cells from the Basal Compartment Scientists report that the type 2 FGF receptor (FGFR2) signaling axis is crucial for preserving stemness and preventing differentiation of prostate stem cells. Ablation of Fgfr2 in vivo reduces number of P63-expressing basal cells and enriches luminal cells. [J Biol Chem] Abstract | Press Release Clinical Significance of CUL4A in Human Prostate Cancer The authors investigated the possible role of cullin 4A (CUL4A) in prostate tumorigenesis. CUL4A knockdown with siRNA in prostate cancer cells decreased cell proliferation, migration, and invasion. [Tumor Biol] Abstract Curcumin Inhibits Growth of Prostate Carcinoma via miR-208-Mediated CDKN1A Activation Researchers studied the effects of low-dose curcumin on prostate cancer (PC) cell growth. Curcumin dose-dependently inhibited the proliferation of PC cells, without affecting cell apoptosis. [Tumor Biol] Abstract Enhanced Regulation of Cell Cycle and Suppression of Osteoblast Differentiation Molecular Signatures by Prostate Cancer Stem-Like Holoclones LNCaP and PC3 parent cells were capable of responding to stem cell differentiation morphogen retinoic acid, suggesting the presence of inherent stem-like properties. LNCaP cells, which represent early, androgen-responsive disease, formed holoclones after twenty six days. [J Clin Pathol] Abstract CLINICAL RESEARCH Androgen Deprivation Therapy plus Docetaxel and Estramustine versus Androgen Deprivation Therapy Alone for High-Risk Localized Prostate Cancer (GETUG 12): A Phase III Randomized Controlled Trial Researchers assessed the effects of combined docetaxel and estramustine on relapse in patients with high-risk localized prostate cancer. [Lancet Oncol] Abstract | Commentary A Phase I Study of Muscadine Grape Skin Extract in Men with Biochemically Recurrent Prostate Cancer: Safety, Tolerability, and Dose Determination MPX is pulverized muscadine grape (Vitis rotundifolia) skin that contains ellagic acid, quercetin, and resveratrol and demonstrates preclinical activity against prostate cancer cells in vitro. In the Phase I portion of this Phase I/II study, non-metastatic biochemically recurrent prostate cancer patients were assigned to increasing doses of MPX. [Prostate] Abstract |